May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects